is metformin semaglutide + Together: Safety & Efficacy – PlexusDx Treatment of Diabetes and Obesity

In late October 2025 Novo unveiled an unsolicited $6.5 billion cash offer (potentially rising to ~$9.0 billion with contingencies) for Metsera ( [3] )

It is unclear whether the diverse functions attributed to NKT cells reflect true functional heterogeneity or result from the coexistence of distinct NKT cell subsets

How unusual is it for so many patients to be eligible for a new class of drugs but face such a high cost

Driving GLP-1 Shipping Success with Nordic At Nordic Cold Chain Solutions, we recognize that shipping GLP-1 medications demands more than passive coolingit requires a fully validated logistics strategy grounded in clinical precision